News and Events

The new weekend article from George is dedicated to pesticide discovery – an important research topic. Check out the full text to find out more about the application of spiro compounds in this field and browse through Chemspace Spiro Fragments Collection!

We are happy to continue our series of posts which are inspired by Drug Hunter’s “Molecules of the Month”!
Here are two molecules that were recently highlighted by Drug Hunter!

Happy Valentine's Day from Chemspace team!

Cheers to all the couples out there!

Join the Chemspace & Hitgen Webinar 'Advancing Fully Open Access: OpenDEL as a Self-serve DNA-Encoded Library Kit Benefits Your Drug Discovery Research', which will take place at 4:00 PM (CET) / 7:00 AM (PST) on February 22nd, 2023.

The Speaker is Dr. Guansai Liu, Vice President at Hitgen Inc. Hosted by Dr. Olga Tarkhanova.

Register via the link now!

A new post in the Biologics campaign is out! We offer products for studying the LRRK2 signaling pathway. Follow the link and find out how LRRK2 mutations may mediate neurodegeneration and cause Parkinson's disease. Check out Chemspace Biologics!

Check out the new post in the #Meet_Chemspace_Team series to get to know our prominent Account Manager Dmytro Ilnytskyi! Follow the link and find out more about his hobbies, snowboarding, and the beauty of Ukrainian mountains!

Check out the new featured article on sulfur (VI) fluorides that George prepared for you! We are also offering a compound set of selected sulfur (VI) fluorides that are available for purchase at Chemspace!

Meet Chemspace Monthly Digest! 

Here is a summary of all Chemspace news and highlights for January in case you have missed them!

Meet a new post in the Biologics campaign! We offer products for studying the KRAS-mediated signaling pathways. Follow the link and find out how various KRAS mutations lead to oncogenesis. Check out Chemspace Biologics!

We are happy to continue our series of posts which are inspired by Drug Hunter’s “Molecules of the Month”!
Here are two molecules that were recently highlighted by Drug Hunter!

Chemspace and the University of Southern California collaborate to make Giga-scale docking accessible!

Chemspace receives access to V-SYNTHES, a technology that is the first to make accessible virtual screening of multi-billion-sized chemical spaces. Now we can screen vast amounts of compounds in a reasonable time while also drastically reducing the cost compared to classical VLS.

Check out a great review on successful fragment-to-lead campaigns in 2021 and the 11 Fragments Sets Chemspace has to offer! The full post is here!

Today we will get even closer to you as we introduce Aliona Savich, the Product Owner at Chemspace! Follow the link to read the full post!

Last December Adagrasib (KRAZATI) received approval by the FDA as a drug for treating NSCLC with KRAS^G12C mutation. It is an irreversible inhibitor with a warhead that unalterably binds to the target.

We offer you 40 Covalent Modifiers sets with versatile binders, which could be the perfect start for your research in anti-cancer and other medications!

Check out the new press release, where Enamine and UORSY announce their collaboration on creating Legacy Screening Collection – 1.22 million compounds! The set is already available for purchase on the Chemspace website!

Meet a new post in the Biologics campaign! We offer products for studying the FGFR signaling pathways. Follow the link and find out how FGFR deregulation is involved in cancer development. Check out Chemspace Biologics!

We are happy to continue our series of posts which are inspired by Drug Hunter’s “Molecules of the Month”!
Here are two molecules that were recently highlighted by Drug Hunter!

This week was super productive in terms of publications! Today we present a paper co-authored by Dmytro Dudenko, where the authors developed a novel synthesis protocol to make a 600k compound chemical space available for synthesis.

We are proud to present a new Chemspace co-authored article! 
Follow the link to find out more about the structure-based discovery of SARS-CoV-2 Macrodomain inhibitors!

Meet Chemspace Monthly Digest! 

Here is a summary of all Chemspace news and highlights for December in case you have missed them!

Happy New Year from the whole Chemspace Team and our Mascots!
Enjoy the celebration and see you next year!

George hopes that you all had a great Christmas and today he is here to present a new article to you! Find out more about chalcogen-containing compounds in the treatment of neglected tropical diseases here!

We are sending you our best wishes for a fabulous festive season from across the miles.

NDI-034858 (TAK-279) is a TYK2 inhibitor now in Phase 2 for treating plaque psoriasis. It contains pyrazolopyrimidine moiety. We offer a set of in-stock BBs with such parts.

Meet a new post in the Biologics campaign! We offer products for EGFR signaling pathway studies. Follow the link and find out how EGFR inhibitors are involved in cancer treatment. Check out Chemspace Biologics!